PF-Atlas › Clinical Trials › NCT02163642

Role of Innate Immunity in Non-Cystic Fibrosis Bronchiectasis

Cyranose® 320 · Not specified

Registry ID

NCT02163642

Phase

Not specified

Status

Unknown

Drug / intervention

Cyranose® 320

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Start

2014-04

About this trial

Cyranose® 320 is evaluated in NCT02163642, a idiopathic pulmonary fibrosis study sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. Current status: Unknown.

View NCT02163642 on ClinicalTrials.gov →

Explore related

All Cyranose® 320 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT02163642 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.